Spirotome Concept Sales Guide
description
Transcript of Spirotome Concept Sales Guide
Spirotome Concept Sales Guide
Version 2012
Click to edit Master title styleSpirotome 8-10-14G• Trocar
• Helix needle
• Cutting cannula
• Release element
FIRST ManualVacuum & Macro
Biopsy System
CE & FDA Approved for 13 different applications
Click to edit Master title styleHow it works?
1.Searching 2.Penetration
3.Cutting 4.Retrieving
Spirotome Technology
Click to edit Master title styleSpirotome Training Program
Identify
Attract
Engage
Ret
ain
Customer RelationshipProduct awarenessProduct Workshop, Application Fields & Procedure Training
Follow Up & Feedback
Define Needs
Training Program
Procedure Support
Spirotome Solution
Define Needs: Radiologist is team player
Click to edit Master title styleSpirotomePhysician • Full control during the procedure. NO shooting or ballistic effect, avoiding vital or impenetrable organs to
be accidentally touched (for example lungs, vascular vessels or bones )• High visibility for an improved targeted navigation • Single insertion biopsy technique• No collateral damage and lower complication rates • High quality sample with a maximal tissue / needle ratio (up to 300mg)• Easy to handle and to fix into the lesion. Accessible to superficial, deeper and delicate lesions.• No cell spreading by shooting effect• Compatible and highly efficient solution for different imaging techniques (Ultrasound, CT, MRI , Stereotactic
Mammography …)
Pathologist • High quality sample qualified for molecular biology • Complete & adequate information is important for a efficient & reliable diagnose and treatment selection
Patient • More efficient treatment selection thanks to a targeted high quality tissue sample within a shorter delay• Virtually painless, silent and patient friendly procedure• Minor bleeding & minor risk for infections• Reliable diagnosis without surgery (local anesthesia)
Cost-efficiency • Low Overhead Costs : • Procedure can be done virtually everywhere (no Operating Room required)• No assistance or preparation time is needed (Spirotome Biopsy can be done in less than 10min)• High quality tissue sample with exact targeting, avoids false negatives
• Low Material Cost : • Only manually operated (vacuum-assisted) macro biopsy device• Full reimbursment for Breast Diagnosis (RIZIV code 688472)• Can avoid surgical intervention in delicate procedures. • No accessories are needed, in contrast to other vacuum assisted biopsy systems
Click to edit Master title styleSpirotome Concept Stakeholders
Radiologist/interventionist Pathologist Oncologist Purchasing Dept
- Product - technical advantages- Clinical advanatages- Patient comfort- Pricing / reimbursement
- TISSUE is the ISSUE-Superior tissue sample quality- opening gates to molecular biology- personalized diagnostics
-More efficient treatment selection- increase success-rate of targeted treatments- personalized therapy
-Pricing - reimbursed vs non-reimbursed indications- added value of Spirotome concept in the diagnostic & therapeutic process-- Spirotome is a universal product in various fields
The Spirotome
CLINICAL EVIDENCE
European Journal of Cancer Prevention, Vol 13, Issue 6, pp 491-498, 2004
Dr. Melcior Sentis (Barcelona)
SPIROTOME ON STEREOTACTIC TABLE
MRI CONDITIONAL Certified testing on Tesla 3:
◦ ASTM F2052 for displacement force
◦ ASTM F2213 for induced torque
◦ ASTM F2182 for induced heating
◦ ASTM F2119 for image artifact
Clinical tests show no interference nor safety issues.
Image artifact lower with Teflon trocar
Solved problems of the needle point
1 cm before the receiving space
0.5 to 0.7 cm ø System 3 cm under the skin Lateral uptake: out of target
= > 6 to 24 samples
Microcalcifications
Harries R, Lawson S, Bruckers Liesbeth. Assessment of microcalcifications with limited number of high-precision macrobiopsies. Eur J Cancer Prev 2010; 19: 374-8.
EXTREME CONDITIONS
Small breasts and peripheral tumors
Subcutaneous areas Subareolar disease Tumors close to bony or
delicate structures
Health Care System
No capital investment On the average 1
macrobiopsy per week ? Affordable biopsies = more
experience = broadening of indications
Indication:BIRADS 4 LESIONS
CONVINCING ?
Benefits for: Patient Pathologist Oncologist Operator Health Care System
Lung applications
Musceloskeletal applications
JL Gielen, AM De Schepper, M Blom, P Van Dyck, D Creytens, J Veryser, J Somville, PM Parizel.Experience with a novel frontal core biopsy device in soft tissue and bone lesions. Skeletal Radiol 2011; 40:
Head & Neck applicationsStrong demand for macrobiopsies for molecular biology
Thyroid applications
ImicroRNA and Thyroid CancerHoney Reddi, Ph.D., Assistant Professor, Medicine, Mayo Clinic
Thyroid cancer accounts for 96% of endocrine malignancies affecting about 3 million individuals in the U.S.
Pre-operative assessment of thyroid nodules by currently used cytological methods poses a significant clinical challenge due to a 20% non-diagnostic rate.
This results in unnecessary surgical intervention, wherein only 8-17% of cases are malignant, thereby prompting the need for additional methods of detection.
Lymph node applications- Breast cancer: axillary node- Staging of any cancer- Cancer of unknown primary- PET-CT follow-up
Liver biopsyD Nasr, LL Bidot, M Roche, S Paveliu, P Morel, A Naouri, E Odet, P Esquis, F Pilleul, P Bernard. Maladie des complexes de von Meyenburg (micro-harmatomes biliaires) découverte lors d’une chirurgie laparoscopique (Spirotome): à propos de deux observations. Von Meyenburg disease found during laparoscopic surgery (Spirotome): report of two cases. Annales de Chirurgie 131: 468470, 2006.
Liver biopsies
Liver biopsies under ultrasoundDr. Biguet – CHR – Verviers“Spirotome and microbubles the max for liver diagnostics.”
CEUSWith laparoscopic assistance
M, Barbaret V, Chiers K, Duchateau L, Bacci B, Terragni R, Rossi F, Sounders JH. Evaluation of a manual biopsy device («Spirotome ») on fresh canine organs : liver, spleen and kidneys and first clinical experience in animals. Eur J Cancer Prev 2011; 20: 140-5.
Blind
Deeper samoles Deeper samples Deep biopsies Deep biopsies
Gynecologists Gynecologists, oncologists, radiotherapists
Gynecologists, IVF,
Gynecologists
Complete diagnosis
Importance of stromal factors
Importance of transition zone
Importance of deep biopsies
new concepts in gynecology
New concepts in gynecology, less destruction, painfree
New concepts in stromal factors
new concepts in staging laparotomy
Punch Forceps Forceps Forceps
habits habits habits Combination with endoscopes
Uniqueness
Primary call points
Strategy
Opportunity
Predicate device
Challenges
Vulva Cervix Uterus Abdomen
Gynecological applications
VulvaCervixUterusAbdominalTer Brugge
Campo
Gordts
Ter Brugge H. Laparoscopic staging with a new direct and frontal biopsy instrument. J Gynecologic Surgery 2011; in press.
Cervicore: Key to Terra Incognita
Importance of stroma for Cervix
Sahebali S, Van den Eynden G, Murta E, Michelin M, Cusumano P, Petignat P, Bogers J.
Stroma issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development.
Eur J Cancer Prev 2010; 19: 204-215
Click to edit Master title styleSpirotome Training Program
Identify
Attract
Engage
Ret
ain
Customer RelationshipProduct awareness
Product Workshop & procedure training
Follow Up & Feedback
Define Needs
Training Program
Procedure Support
Spirotome Solution
Click to edit Master title styleCONCLUSION
Personalized Medicine• Cytostatics• Hormones• Growth inhibitors• Monoclonal
antibodies…
Personalized Diagnostics• Pathology• Immuno-
histochemistry• Molecular biology…
Macrobiopsy• Enough tissue• Representative tissue• Fresh
Implementing clinical use of personalized diagnostics can stratify patients, give molecular classification of disease, determine the likelihood of occurrence, and recommend the best course of treatment. These approaches promise to reduce costs in healthcare,improve treatment, and have the potential to provide consumer-driven access to health information. But how will we acquire tissue to fulfill all these opportunities ? Cambridge Healthtech Institute
Kuringersteenweg 304B-3500 Hasselt
tel: +32 (0)11 271557fax: +32 (0)11 283677
BE 0449 067 537
Thank you for your attention !